Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Immunotherapy for Liver Transplant Patients With Hepatocellular Carcinoma: Anti-tumor Effect of IL2-activated Donor Liver Natural Killer Cell

NCT01147380 is registered in ClinicalTrials.gov with Seigo Nishida as lead sponsor.

NCT NCT01147380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01147380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Immunotherapy for Liver Transplant Patients With Hepatocellular Carcinoma: Anti-tumor Effect of IL2-activated Donor Liver Natural Killer Cell
Lead sponsor
Seigo Nishida
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2014
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evidence of liver transplantation, hepatocellular carcinoma, liver cirrhosis